Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

53.84
+0.18000.34%
Post-market: 53.890.0500+0.09%19:52 EDT
Volume:1.58M
Turnover:84.69M
Market Cap:4.31B
PE:-14.24
High:53.87
Open:53.67
Low:53.63
Close:53.66
52wk High:58.40
52wk Low:21.34
Shares:79.99M
Float Shares:67.77M
Volume Ratio:0.33
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7801
EPS(LYR):-3.7544
ROE:-31.14%
ROA:-20.36%
PB:4.20
PE(LYR):-14.34

Loading ...

Akero Therapeutics rises 16.5%

TIPRANKS
·
Oct 09

BREAKINGVIEWS-Novo Nordisk’s liver deal misses bigger ailment

Reuters
·
Oct 09

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires Live
·
Oct 09

Novo Nordisk Exec Says Co Will Be Open to More Innovative Deals -Conf Call

THOMSON REUTERS
·
Oct 09

Novo Nordisk to Acquire Akero Therapeutics to Expand MASH Portfolio

TIPRANKS
·
Oct 09

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines

Reuters
·
Oct 09

Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease

Dow Jones
·
Oct 09

Akero Therapeutics Rockets 19% as Novo Nordisk to Buy It for up to $5.2 Billion

Reuters
·
Oct 09

Akero Therapeutics jumps 18% to $54.74 after Novo Nordisk buyout offer

TIPRANKS
·
Oct 09

Akero Therapeutics Shares Rise 16.7% Premarket After Novo Nordisk to Acquire Co for up to $5.2 Billion

THOMSON REUTERS
·
Oct 09

Akero Therapeutics Inc - Shareholders to Receive $54 per Share in Cash

THOMSON REUTERS
·
Oct 09

Akero Therapeutics to Be Acquired by Novo Nordisk for up to $5.2 Billion

THOMSON REUTERS
·
Oct 09

Novo Nordisk to acquire Akero Therapeutics for 47 billion USD plus potential milestone payment

Reuters
·
Oct 09

NOVO NORDISK - TRANSACTION WILL BE MAINLY DEBT FINANCED

THOMSON REUTERS
·
Oct 09

Akero Therapeutics Announces New Phase 2b Clinical Data for Efruxifermin in MASH at Upcoming AASLD 2025 Liver Meeting

Reuters
·
Oct 07

Akero Therapeutics COO Jonathan Young Reports Disposal of Common Shares

Reuters
·
Oct 04

Akero Therapeutics Announces Full Prepayment of $37.6 Million Loan, Terminates Debt Agreement with Hercules Capital

Reuters
·
Sep 30

Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Sep 19

Strategic Value and Market Positioning Drive Buy Rating for Akero Therapeutics

TIPRANKS
·
Sep 18

COO Jonathan Young Reports Disposal of Akero Therapeutics Inc. Common Shares

Reuters
·
Sep 13